Richard M. Marsh, V.P, General Counsel at MYRIAD GENETICS INC (MYGN), sold 11,000 shares at $85.00 ($935K) on 2009-02-04, disclosed to the SEC on 2009-02-04.
Scheduled sale ($935k) by V.P, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.00 | 10,763 | $915K | 97.8% |
| 2 | $85.00 | 237 | $20K | 2.2% |
| Total | $85.00 avg | 11,000 | $935K | 100% |
| Filing → |
| MYGN | SELL | 2018-06-01 | $1.3M | — | Filing → |
| MYGN | SELL | 2018-01-22 | $3.0M | — | Filing → |
| MYGN | SELL | 2018-01-19 | $1.5M | — | Filing → |